Sarepta Therapeutics, Inc. (SRPT)
15.68
-0.20
(-1.26%)
USD |
NASDAQ |
Jul 24, 16:00
15.76
+0.08
(+0.51%)
After-Hours: 20:00
Sarepta Therapeutics Max Drawdown (5Y) : 93.33% for June 30, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| June 30, 2026 | 93.33% |
| May 31, 2026 | 93.33% |
| April 30, 2026 | 93.33% |
| March 31, 2026 | 93.33% |
| February 28, 2026 | 93.33% |
| January 31, 2026 | 93.33% |
| December 31, 2025 | 93.33% |
| November 30, 2025 | 93.33% |
| October 31, 2025 | 93.33% |
| September 30, 2025 | 93.33% |
| August 31, 2025 | 93.33% |
| July 31, 2025 | 93.33% |
| June 30, 2025 | 90.43% |
| May 31, 2025 | 80.27% |
| April 30, 2025 | 72.42% |
| March 31, 2025 | 64.93% |
| February 28, 2025 | 64.93% |
| January 31, 2025 | 64.93% |
| December 31, 2024 | 64.93% |
| November 30, 2024 | 64.93% |
| October 31, 2024 | 64.93% |
| September 30, 2024 | 64.93% |
| August 31, 2024 | 64.93% |
| July 31, 2024 | 64.93% |
| June 30, 2024 | 64.93% |
| Date | Value |
|---|---|
| May 31, 2024 | 64.93% |
| April 30, 2024 | 64.93% |
| March 31, 2024 | 64.93% |
| February 29, 2024 | 64.93% |
| January 31, 2024 | 64.93% |
| December 31, 2023 | 64.93% |
| November 30, 2023 | 64.93% |
| October 31, 2023 | 64.93% |
| September 30, 2023 | 64.93% |
| August 31, 2023 | 64.93% |
| July 31, 2023 | 64.93% |
| June 30, 2023 | 64.93% |
| May 31, 2023 | 64.93% |
| April 30, 2023 | 64.93% |
| March 31, 2023 | 64.93% |
| February 28, 2023 | 64.93% |
| January 31, 2023 | 64.93% |
| December 31, 2022 | 64.93% |
| November 30, 2022 | 64.93% |
| October 31, 2022 | 64.93% |
| September 30, 2022 | 64.93% |
| August 31, 2022 | 64.93% |
| July 31, 2022 | 64.93% |
| June 30, 2022 | 64.93% |
| May 31, 2022 | 64.92% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 88.96% |
| Moderna, Inc. | 95.38% |
| Twist Bioscience Corp. | 94.48% |
| Revolution Medicines, Inc. | 73.29% |
| Foghorn Therapeutics, Inc. | 89.10% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -31.02 |
| Beta (5Y) | 0.2074 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 60.90% |
| Historical Sharpe Ratio (5Y) | -0.4759 |
| Historical Sortino (5Y) | -0.6827 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 32.26% |